BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 32255119)

  • 1. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus.
    Ortega A; Martinez-Arroyo O; Forner MJ; Cortes R
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications.
    Amiri A; Bagherifar R; Ansari Dezfouli E; Kiaie SH; Jafari R; Ramezani R
    J Transl Med; 2022 Mar; 20(1):125. PubMed ID: 35287692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome: From biology to drug delivery.
    Baruah H; Sarma A; Basak D; Das M
    Drug Deliv Transl Res; 2024 Jun; 14(6):1480-1516. PubMed ID: 38252268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial exosomes for translational nanomedicine.
    Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX
    J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges.
    Shahabipour F; Banach M; Sahebkar A
    Arch Med Sci; 2016 Dec; 12(6):1324-1326. PubMed ID: 27904525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
    Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
    Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
    Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
    Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy.
    Quadri Z; Elsherbini A; Bieberich E
    Pharmacol Res; 2022 Jan; 175():105980. PubMed ID: 34863822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
    Syn NL; Wang L; Chow EK; Lim CT; Goh BC
    Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From structures to functions: insights into exosomes as promising drug delivery vehicles.
    Ren J; He W; Zheng L; Duan H
    Biomater Sci; 2016 May; 4(6):910-21. PubMed ID: 26977477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
    Batrakova EV; Kim MS
    J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
    Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
    J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
    Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics.
    Tenchov R; Sasso JM; Wang X; Liaw WS; Chen CA; Zhou QA
    ACS Nano; 2022 Nov; 16(11):17802-17846. PubMed ID: 36354238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.